Informações:
Falhas:
ID
34213
Descrição
Effects of Hyperglycemia on Myocardial Perfusion in Humans With and Without Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT01021865
Link
https://clinicaltrials.gov/show/NCT01021865
Palavras-chave
Versões (1)
- 15/01/2019 15/01/2019 -
Titular dos direitos
see on clinicaltrials.gov
Transferido a
15 de janeiro de 2019
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Coronary Artery Disease NCT01021865
Eligibility Coronary Artery Disease NCT01021865
- StudyEvent: Eligibility
Similar models
Eligibility Coronary Artery Disease NCT01021865
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
ID.1
Item
males and females
boolean
ID.2
Item
age 40-60 years
boolean
ID.3
Item
bmi< or = 35 kg/m2
boolean
ID.4
Item
diabetic subjects with hba1c concentrations of < or = 8%.
boolean
ID.5
Item
diabetic subjects will be either on diet and lifestyle therapy alone, or monotherapy with metformin or sulphonylureas (except glyburide).
boolean
ID.6
Item
all diabetic subjects should be on stable dose oral agent therapy for 3 months prior to enrollment.
boolean
ID.7
Item
subjects with cerebrovascular or peripheral vascular disease.
boolean
ID.8
Item
subjects with suspected or overt autonomic neuropathy.
boolean
ID.9
Item
diabetic subject on thiazolidinediones, insulin, glp-1 based therapies (exenatide or sitagliptin), alpha-glucosidase inhibitors, glyburide or combination antidiabetic drug therapies.
boolean
ID.10
Item
diabetics with microalbuminuria.
boolean